A detailed history of Sg Americas Securities, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sg Americas Securities, LLC holds 107,725 shares of NVO stock, worth $9.43 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
107,725
Previous 22,453 379.78%
Holding current value
$9.43 Million
Previous $2.67 Million 246.69%
% of portfolio
0.04%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$85.0 - $120.04 $7.25 Million - $10.2 Million
85,272 Added 379.78%
107,725 $9.27 Million
Q3 2024

Oct 03, 2024

SELL
$119.07 - $145.42 $3.64 Million - $4.44 Million
-30,554 Reduced 57.64%
22,453 $2.67 Million
Q2 2024

Jul 12, 2024

SELL
$122.71 - $146.91 $49.1 Million - $58.8 Million
-400,273 Reduced 88.31%
53,007 $7.57 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $32.2 Million - $42.8 Million
315,191 Added 228.25%
453,280 $58.2 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $12.1 Million - $14.6 Million
138,089 New
138,089 $14.3 Million
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $4.94 Million - $5.94 Million
37,303 Added 231.48%
53,418 $8.5 Million
Q4 2022

Feb 02, 2023

BUY
$102.55 - $135.33 $1.65 Million - $2.18 Million
16,115 New
16,115 $2.18 Million
Q2 2022

Jul 29, 2022

SELL
$103.24 - $121.81 $630,073 - $743,406
-6,103 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$93.1 - $112.54 $235,263 - $284,388
-2,527 Reduced 29.28%
6,103 $678,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $533,476 - $651,433
5,564 Added 181.47%
8,630 $967,000
Q3 2021

Nov 01, 2021

BUY
$84.42 - $106.62 $258,831 - $326,896
3,066 New
3,066 $294,000
Q2 2021

Aug 12, 2021

SELL
$67.66 - $84.76 $227,946 - $285,556
-3,369 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $225,925 - $255,437
3,369 New
3,369 $227,000
Q2 2020

Jul 20, 2020

SELL
$58.54 - $67.94 $4 Million - $4.64 Million
-68,289 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$49.46 - $64.78 $3.14 Million - $4.11 Million
63,426 Added 1304.26%
68,289 $4.11 Million
Q4 2019

Jan 28, 2020

SELL
$49.86 - $58.26 $249,399 - $291,416
-5,002 Reduced 50.7%
4,863 $281,000
Q2 2019

Jul 29, 2019

BUY
$46.79 - $52.47 $461,583 - $517,616
9,865 New
9,865 $504,000
Q1 2019

Apr 29, 2019

SELL
$46.36 - $52.63 $543,849 - $617,402
-11,731 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$41.54 - $47.25 $487,305 - $554,289
11,731 New
11,731 $540,000
Q2 2018

Aug 07, 2018

SELL
$44.29 - $50.42 $597,250 - $679,913
-13,485 Closed
0 $0
Q1 2018

May 03, 2018

SELL
$48.49 - $58.14 $358,050 - $429,305
-7,384 Reduced 35.38%
13,485 $664,000
Q4 2017

Jan 24, 2018

BUY
$47.53 - $53.73 $991,903 - $1.12 Million
20,869
20,869 $1.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.